Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Mindray, officially known as Shenzhen Mindray Bio-Medical Electronics Co., Ltd., is a leading Chinese company specialising in medical, precision, and optical instruments, including watches and clocks. Headquartered in Shenzhen, China, the firm has established a significant presence across Asia, North America, and Europe, serving a global healthcare market. Founded in 1991, Mindray has grown to become a prominent player in medical imaging, patient monitoring, and laboratory diagnostics, recognised for its innovative technology and reliable products.
The company's core offerings include advanced medical devices such as ultrasound systems, patient monitors, and in-vitro diagnostic instruments, distinguished by their high quality and affordability. With a strong market position, Mindray continues to expand its footprint through technological innovation and strategic partnerships, maintaining its reputation as a trusted provider in the medical equipment industry.
0 vs industry average
Mindray’s score of 32 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing is among the most carbon-intensive industries
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Mindray, a Chinese medical, precision, and optical instruments company, reported Scope 1 emissions of 5,327,980 kg CO2e, Scope 2 emissions of 68,619,750 kg CO2e, and Scope 3 emissions of 94,210,380 kg CO2e for 2024. This data is cascaded from its parent company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
In 2023, Mindray's Scope 1 emissions were 7,207,560 kg CO2e and Scope 2 emissions were 67,978,550 kg CO2e. For 2022, these figures were 6,806,130 kg CO2e for Scope 1 and 64,620,020 kg CO2e for Scope 2.
Mindray has committed to reducing its Scope 1 and Scope 2 GHG emission intensity by 25% by 2030, compared to a 2021 baseline.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more